| Date | Title | Description |
| 10.05.2017 | INC Research and inVentiv Health to Merge | Creates a Leading Global Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3.2 Billion |
| 06.02.2017 | LabCorp reportedly planning $8B buyout of CRO | In an emailed statement, a LabCorp spokesperson said the company does not comment on market rumors.
It’s not the first time M&A negotiations have been leaked. In April 2016, Bloomberg reported that LabCorp was in talks to acquire INC Re... |
| 16.08.2016 | INC Research Announces Secondary Offering and Repurchase of Common Stock | Raleigh, N.C., August 16, 2016 – (GLOBE NEWSWIRE) — INC Research Holdings, Inc.(Nasdaq:INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, na... |
| 01.08.2016 | INC Research Announces Secondary Offering | Raleigh, N.C., August 1, 2016 – (GLOBE NEWSWIRE) — INC Research Holdings, Inc. (Nasdaq: INCR) (the “Company”), a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, n... |
| 01.03.2012 | INC Research tops CRO quality ranking as M&A shapes pharma outsourcing | Before acquiring Kendle last year, INC was a mid-sized CRO whose size and pharmaceutical outsourcing service offerings fell well short of the largest CROs such as Quintiles and Parexel. Raleigh, North Carolina-based INC’s service quality me... |
| 29.02.2012 | INC Research Achieves Most Consistent Service Quality Ratings in the CRO Industry According to the CRO Quality Benchmarking Report | Raleigh, N.C., Feb. 29, 2012 – INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the Company has received the “most consistent service ... |
| 23.12.2011 | A clinical research organization wish list for Christmas (and new year) | A strategic partner: The biggest CROs such as, Quintiles, PPD, and Covance (NYSE:CVD) are increasingly moving toward strategic partnerships, making them a “preferred provider” of services. In these arrangements, a pharma will contract with ... |
| 16.08.2011 | PPD in ‘exclusive talks’ with Carlyle Group about M&A deal, reports say | Several private equity firms expressed interest, including Blackstone Group (NYSE:BX), KKR & Co. and Hellman & Friedman, two unnamed sources told Bloomberg. Carlyle’s bid topped all of them. Bids were between $33 and $38 a share — a... |
| 02.06.2011 | INC Research buys Australian CRO Trident to boost global presence | “Trident is an important piece in our strategy to build a sustainable CRO business that both satisfies and anticipates the global drug development needs of our customers,” INC Research CEO James Ogle said in a statement.
Adelaide, Australia... |
| 10.05.2011 | PPD expands consulting division, signals areas for CRO growth | “We have aligned our consulting practice to the areas where we continue to see a strong need for our services to help our clients address significant regulatory and market challenges,” Chief Medical Officer Dr. Christine Dingivan said in a ... |
| 04.05.2011 | INC Research to Acquire Kendle International for $15.25 per Share in Cash | Cincinnati, OH and Raleigh, N.C., May 4, 2011 – INC Research, LLC, a therapeutically focused global contract research organization (CRO) privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan, and Kendle International ... |
| 03.03.2011 | INC Research brings on new CFO, aims to crack CRO industry’s top 5 | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| 19.01.2011 | Quintiles layoffs consistent with CRO industry | Quintiles is laying off workers again. The Durham, North Carolina-based clinical research organization is laying off workers in a "small employee action," according to LocalTechWire.
Quintiles, a privately held company, isn’t disc... |
| 18.01.2011 | INC Research bolsters its pharma consulting arm with acquisition | “For example, we work with customers to reach proof of concept faster and at lower cost while carrying these efficiencies over to the later stages of clinical development,” he said.
AVOS also expands INC Research’s Alliance Partnerships uni... |
| - | LabCorp reportedly planning $8B buyout of CRO | Burlington, North Carolina-based LabCorp is rumored to be negotiating an $8 billion acquisition of Pharmaceutical Product Development (PPD), a global contract research organization operating in over 50 countries.
Reuters broke the story on ... |
| - | INC Research buys Australian CRO Trident to boost global presence | INC Research, still completing its $232 million acquisition of clinical research organization Kendle (NASDAQ:KNDL) , has bought yet another CRO to add to its global footprint.
Raleigh, North Carolina-based INC Research has acquired Australi... |
| - | PPD in ‘exclusive talks’ with Carlyle Group about M&A deal, reports say | Clinical research organization PPD (NYSE:PPDI) is talking with private equity firm The Carlyle Group about an M&A deal.
Bloomberg News reports that Carlyle is in exclusive talks to possibly acquire Wilmington, North Carolina-based PPD, ... |
| - | PPD expands consulting division, signals areas for CRO growth | PPD (NYSE:PPDI) is expanding its consulting services into four new areas, signaling the kinds of services that the Wilmington, North Carolina clinical research organization believes will be growth opportunities.
The CRO’s consulting arm, PP... |
| - | A clinical research organization wish list for Christmas (and new year) | North Carolina clinical research organization PPD got an early Christmas present with the completion of its $3.9 billion acquisition by private equity firms The Carlyle Group and Hellman & Friedman.
Talks about the CRO acquisition began... |
| - | INC Research tops CRO quality ranking as M&A shapes pharma outsourcing | Among clinical research organizations, INC Research is not the biggest, but by at least one measure, it stands out as the best.
INC received the best service quality scores in the annual CRO quality benchmarking study conducted by Industry ... |
| - | INC Research bolsters its pharma consulting arm with acquisition | Clinical research organization INC Research is boosting its ability to work with pharmaceutical companies as a partner in drug development with an acquisition that adds to its own consulting arm.
Raleigh, North Carolina-based INC Research a... |
| - | INC Research Further Expands Geographic Footprint with Acquisition of Leading Middle Eastern CRO MEK Consulting | Acquisition provides customers improved access to Middle East and North Africa region as well as Southern Europe
Raleigh, N.C., March 6, 2014 – INC Research LLC, a therapeutically focused global clinical research organization (CRO) with a ... |
| - | INC Research brings on new CFO, aims to crack CRO industry’s top 5 | INC Research, a North Carolina clinical research organization, has hired its new chief financial officer from the ranks of a fellow North Carolina company as it charts a growth course to make the Raleigh firm one of the biggest players in t... |
